Joint (JYNT) EBIT Margin (2013 - 2026)

Joint (JYNT) posted EBIT Margin of 5.9% for Q1 2026, up 20.43% sequentially from 4.89% in Q4 2025, and up 1108.0% YoY from 0.49% in Q1 2025.

Joint (JYNT) EBIT Margin (2013 - 2026) Analysis & Trends

Joint has reported EBIT Margin for 14 years, with the latest figure at 5.9% in Q1 2026.

Quarterly EBIT Margin rose 1108.0% year-over-year to 5.9% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.13% (up 516.0% YoY) and the FY2025 annual result came in at 1.66%, up 196.0% from the prior year.
EBIT Margin grew to 5.9% in Q1 2026 per JYNT's latest filing, from 4.89% in the prior quarter.
Over five years, EBIT Margin peaked at 7.83% in Q4 2023 and troughed at 14.11% in Q2 2024.
A 5-year average of 0.75% and a median of 0.17% in 2022 frame the typical range for EBIT Margin.
The sharpest annual moves came in 2022 and 2026: EBIT Margin sank 1817 bps in 2022, then soared 1108 bps in 2026.
Over 5 years, EBIT Margin stood at 5.85% in 2022, then jumped by 34 bps to 7.83% in 2023, then slipped by 30 bps to 5.5% in 2024, then fell by 11 bps to 4.89% in 2025, then rose by 20 bps to 5.9% in 2026.
According to Business Quant data, EBIT Margin over the past three periods registered 5.9%, 4.89%, and 1.2% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBIT Margin (Qtr)
1	HCA Healthcare	88.19 Bn	90.61 Bn	15.19 Bn	-12.60%
2	Tenet Healthcare	21.59 Bn	21.56 Bn	4.45 Bn	26.67%
3	Encompass Health	12.19 Bn	12.86 Bn	1.34 Bn	2.10%
4	Davita	11.52 Bn	12.39 Bn	1.16 Bn	16.29%
5	Ensign	10.59 Bn	10.27 Bn	306.24 Mn	8.50%
6	Universal Health Services	8.79 Bn	8.72 Bn	3.29 Bn	11.14%
7	Pacs	7.04 Bn	6.88 Bn	338.46 Mn	7.66%
8	Chemed	6.96 Bn	6.92 Bn	221.47 Mn	13.25%
9	Concentra Group Holdings Parent	4.52 Bn	4.38 Bn	192.10 Mn	18.99%
10	Joint	119.99 Mn	97.85 Mn	12.70 Mn	-2.43%

Download Data